Peptide Synthesis Market By Peptide Type (Long, Short, Cyclic, Modified), Application (Drug Discovery, Therapeutics, Research, Cosmetics), Technology (Solid Phase, Liquid Phase, Hybrid Phase), & Region For 2024-2031

Peptide Synthesis Market Size And Forecast

Peptide Synthesis Market size was valued at USD 392.44 Million in 2024 and is projected to reach USD 589.68 Million by 2031, growing at a CAGR of 5.76% from 2024 to 2031.

Peptide synthesis is defined as the process by which peptides, short chains of amino acids, are artificially created through the chemical bonding of amino acid residues.

Increasingly recognized for their therapeutic potential, peptides are widely used in various industries, particularly in pharmaceuticals, biotechnology, and research.

The synthesis process can be carried out through two main methods: solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS).

Peptides produced through these methods are utilized for a range of applications, including drug development, diagnostics, and protein studies.

A growing demand for peptide-based therapeutics is being observed across global markets, driven by their advantages in terms of specificity, safety, and effectiveness.

The rising prevalence of chronic diseases, coupled with advancements in biotechnology, has led to the expansion of peptide applications in targeted therapies.

Additionally, the increasing investment in research and development in this area is expected to further boost the peptide synthesis market, contributing to its significant growth in the coming years.

Global Peptide Synthesis Market Dynamics

The key market dynamics that are shaping the global peptide synthesis market include:

Key Drivers:

Demand for Peptide-Based Therapeutics: Growing interest in peptide-based drugs is being driven by their high specificity, safety profile, and effectiveness in treating chronic diseases. The global pharmaceutical industry is anticipated to expand its focus on peptide drugs due to their role in addressing unmet medical needs.

Prevalence of Chronic Diseases: Increasing occurrences of diseases such as cancer, cardiovascular conditions, and metabolic disorders are estimated to drive the demand for innovative treatments like peptide-based therapies. Peptide synthesis is projected to play a critical role in the development of personalized and targeted therapies.

Investment in Biotechnology and Pharmaceutical R&D: Rising expenditures in research and development within the biotechnology and pharmaceutical sectors are expected to fuel advancements in peptide synthesis technologies. These investments are projected to lead to more efficient and scalable synthesis methods, supporting the growing need for peptide therapeutics. The Pharmaceutical Research and Manufacturers of America (PhRMA) reports that in 2019, the biopharmaceutical industry invested an estimated $83 billion in R&D.

Adoption of Solid-Phase Peptide Synthesis (SPPS) Technology: High adoption rates of SPPS, which offers cost-effective and scalable production of complex peptides, are anticipated to drive market growth. SPPS technology is expected to continue being the preferred method due to its ability to support rapid peptide production for research and commercial use.

Key Challenges:

High Production Costs: Hampered by the complex processes involved in peptide synthesis, high production costs are likely to limit market growth. The financial burden associated with advanced equipment and raw materials is projected to deter smaller companies from entering the market.

Restrain Regulatory Challenges: Regulatory challenges surrounding the approval of peptide-based therapeutics are anticipated to restrain the market's expansion. Stringent guidelines and lengthy approval processes are expected to delay the introduction of new products, affecting time-to-market for developers.

Impede Scalability Issues: Scalability issues related to peptide synthesis methods are likely to impede the capacity of manufacturers to meet increasing demand. The challenges associated with transitioning from laboratory-scale production to commercial-scale operations are estimated to create bottlenecks in supply chains.

Limited Shelf Life of Peptides: Limited shelf life of peptide products is projected to hamper market growth, as stability concerns can affect distribution and storage. The necessity for cold-chain logistics and specific handling procedures is expected to increase operational complexities for manufacturers.

Key Trends:

Emphasis on Personalized Medicine: Growing emphasis on personalized medicine is being observed as healthcare shifts towards tailored treatment approaches. The increasing use of peptides as targeted therapies is anticipated to drive innovation in synthesis methods to meet specific patient needs.

Integration of Artificial Intelligence (AI) and Automation: Rising integration of artificial intelligence and automation technologies in peptide synthesis processes is expected to enhance efficiency and reduce production times. These technological advancements are projected to lead to significant cost savings and improved accuracy in synthesis.

Focus on Sustainable Practices: Increasing focus on sustainable practices in peptide synthesis is anticipated as environmental concerns gain prominence in the pharmaceutical industry. Green chemistry approaches and the use of renewable resources are likely to become integral components of the peptide production process.

Investment in Biopharmaceuticals: High investment levels in biopharmaceuticals are being directed towards peptide-based therapeutics, driven by their potential to treat a variety of diseases. This trend is expected to result in accelerated research and development efforts, enhancing market growth.

Global Peptide Synthesis Market Regional Analysis

Here is a more detailed regional analysis of the global peptide synthesis market:

North America:

According to Verified Market Research Analyst, North America is expected to dominate the peptide synthesis market due to its robust biopharmaceutical sector and significant investment in research and development.

The presence of major pharmaceutical companies and cutting-edge biotechnology firms is anticipated to drive advancements in peptide synthesis technologies.

The region's strong regulatory framework and established healthcare infrastructure are projected to facilitate the rapid commercialization of peptide-based therapeutics.

The increasing incidence of chronic diseases in North America is fueling the demand for peptide-based therapeutics. According to the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the United States have a chronic disease, and 4 in 10 have two or more.

Europe:

Europe is anticipated to exhibit rapid growth in the peptide synthesis market, supported by strong government initiatives aimed at fostering innovation in the healthcare sector.

The region's emphasis on personalized medicine and the growing number of clinical trials involving peptides are expected to drive market expansion.

Countries such as Germany, France, and the United Kingdom are likely to emerge as key players, benefiting from well-established pharmaceutical and biotechnology industries.

The rising collaboration between academic institutions and industry stakeholders is projected to enhance research capabilities, further propelling market growth in Europe.

Europe invests heavily in pharmaceutical R&D, a significant portion of which goes into peptide research. The European Commission reports that the EU's investment in R&D reached €311 billion in 2019, representing 2.19% of its GDP.

Global Peptide Synthesis Market: Segmentation Analysis

The Global Peptide Synthesis Market is Segmented on the basis of Peptide Type, Application, Technology, And Geography.

Peptide Synthesis Market, By Peptide Type

• Long
• Short
• Cyclic
• Modified

Based on Peptide Type, the market is bifurcated into Long, Short, Cyclic, and Modified. The long peptides segment is expected to hold the largest share of the peptide synthesis market due to their significant applications in therapeutic development and research. These peptides, typically consisting of more than 20 amino acids, are anticipated to be increasingly utilized in the design of complex biologics, including vaccines and monoclonal antibodies. The rising prevalence of chronic diseases and the need for innovative treatment options are projected to drive demand for long peptides, particularly in oncology and metabolic disorder therapies.

Peptide Synthesis Market, By Application

• Drug Discovery
• Therapeutics
• Research
• Cosmetics

Based on Application, the Global Peptide Synthesis Market is divided into Drug Discovery, Therapeutics, Research, and Cosmetics. The therapeutics segment is expected to hold the largest share of the peptide synthesis market, driven by the increasing demand for peptide-based drugs in various therapeutic areas. The growing prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular disorders, is anticipated to propel the development of innovative peptide therapeutics.

Peptide Synthesis Market, By Technology

• Solid Phase
• Liquid Phase
• Hybrid Phase

Based on Technology, the market is segmented into Solid Phase, Liquid Phase, and Hybrid Phase. Solid-phase peptide synthesis (SPPS) is expected to hold the largest share of the peptide synthesis market due to its established efficiency and scalability in producing peptides. The ability of SPPS to facilitate the rapid assembly of peptide chains while minimizing purification steps is anticipated to drive its widespread adoption among researchers and manufacturers.

Peptide Synthesis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Peptide Synthesis Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to hold the largest share of the peptide synthesis market due to its advanced biopharmaceutical landscape and significant investment in research and development activities. The presence of leading pharmaceutical companies and biotech firms in the United States and Canada is anticipated to drive innovation in peptide synthesis technologies. Additionally, the well-established regulatory framework and infrastructure are likely to facilitate the rapid commercialization of peptide-based therapeutics.

Key Players

The "Global Peptide Synthesis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Merck KGaA, Biotage AB, Gyros Protein Technology, Genscript Biotech, Advanced Chemtech, Beachem Holdings AG, JPT Peptide Technologies, AAPPTec, CSBio Company Inc., and CEM Corporation. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Peptide Synthesis Market Recent Developments
• In June 2022, a new peptide was launched by Evonik to boost the productivity of cell-culture-based biopharmaceuticals. cQrex AC is a chemically defined and highly soluble source of L-cystine that enables a sufficient supply of this key amino acid to cells.
• In January 2023, an agreement to acquire the peptide synthesis company Asymchem was announced by Merck. This acquisition will give Merck access to Asymchem's expertise in peptide synthesis and its global manufacturing network.